• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-(4-羟基苯基)视黄酰胺:与类视黄醇结合蛋白/受体的相互作用。

N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors.

作者信息

Sani B P, Shealy Y F, Hill D L

机构信息

Kettering-Meyer Laboratory, Southern Research Institute, Birmingham, AL 35255-5305, USA.

出版信息

Carcinogenesis. 1995 Oct;16(10):2531-4. doi: 10.1093/carcin/16.10.2531.

DOI:10.1093/carcin/16.10.2531
PMID:7586162
Abstract

The cellular transport, metabolism and biological activity of retinoids are mediated by their specific binding proteins and nuclear receptors. For an understanding of the mode of action of retinoids with potential cancer chemopreventive or other biological activity, it is important to study their interactions with these binding proteins and receptors. In our attempts to understand the action of N-(4-hydroxyphenyl)retinamide (4HPR) and other retinamides in the prevention of cancer, we observed that 4HPR binds to a serum protein with a molecular size of approximately 20,000. The retinoid, however, did not show any binding affinity for cellular retinol-binding protein (CRABP) or for cellular retinoic acid-binding protein (CRABP). However, it showed binding affinity for the nuclear receptors of retinoic acid (RARs) equivalent to 15% of that of retinoic acid. The physicochemical properties of the 4HPR binding protein in the serum were identical to those of serum retinol binding protein (RBP). Antibodies against RBP quantitatively immunoprecipitated the protein-4HPR complex, confirming that the retinoid specifically binds to RBP. Although retinol and 4HPR cross-competed for RBP binding, N-phenylretinamide, in which the 4-hydroxyl group is absent, and N-(4-methoxyphenyl)retinamide, a major cellular metabolite of 4HPR, in which the hydroxyl group is blocked, did not show affinity for the binding protein. The results indicate that the hydroxyl group of 4HPR is essential for binding of this type of retinoid to RBP. Thus, our studies suggest that serum transport of 4HPR may be facilitated by RBP. To bind more efficiently to CRBP, CRABP, or RARs/RXRs, the retinoid may require further metabolic change.

摘要

类视黄醇的细胞转运、代谢及生物活性由其特定的结合蛋白和核受体介导。为了解具有潜在癌症化学预防或其他生物活性的类视黄醇的作用模式,研究它们与这些结合蛋白和受体的相互作用很重要。在我们试图了解N-(4-羟基苯基)视黄酰胺(4HPR)及其他视黄酰胺预防癌症的作用时,我们观察到4HPR与一种分子大小约为20,000的血清蛋白结合。然而,该类视黄醇对细胞视黄醇结合蛋白(CRABP)或细胞视黄酸结合蛋白(CRABP)均未表现出任何结合亲和力。不过,它对视黄酸核受体(RARs)的结合亲和力相当于视黄酸的15%。血清中4HPR结合蛋白的物理化学性质与血清视黄醇结合蛋白(RBP)相同。抗RBP抗体能定量免疫沉淀蛋白-4HPR复合物,证实该类视黄醇特异性结合RBP。虽然视黄醇和4HPR在与RBP结合上存在交叉竞争,但缺乏4-羟基的N-苯基视黄酰胺以及4HPR的主要细胞代谢产物、羟基被封闭的N-(4-甲氧基苯基)视黄酰胺,对该结合蛋白均无亲和力。结果表明,4HPR的羟基对于这类视黄醇与RBP的结合至关重要。因此,我们的研究提示RBP可能有助于4HPR的血清转运。为了更有效地与CRBP、CRABP或RARs/RXRs结合;该类视黄醇可能需要进一步的代谢变化。

相似文献

1
N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors.N-(4-羟基苯基)视黄酰胺:与类视黄醇结合蛋白/受体的相互作用。
Carcinogenesis. 1995 Oct;16(10):2531-4. doi: 10.1093/carcin/16.10.2531.
2
Binding of synthetic analogues of retinol and retinoic acid (CD-270 derivatives) to retinoid-binding proteins.视黄醇和视黄酸的合成类似物(CD - 270衍生物)与类视黄醇结合蛋白的结合。
Skin Pharmacol. 1991;4(3):132-41. doi: 10.1159/000210939.
3
Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.在人血浆中存在且通过诱导细胞色素P450 26A1在人卵巢癌细胞中形成的芬维A胺代谢物4-氧代-芬维A胺的鉴定。
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6265-75. doi: 10.1158/1078-0432.CCR-04-0655.
4
In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences.非维生素A酸与血浆视黄醇结合蛋白的体外相互作用及其功能后果。
FEBS Lett. 1992 Aug 10;308(1):43-5. doi: 10.1016/0014-5793(92)81046-o.
5
Retinoid pathway and cancer therapeutics.视黄醇途径与癌症治疗学。
Adv Drug Deliv Rev. 2010 Oct 30;62(13):1285-98. doi: 10.1016/j.addr.2010.07.003. Epub 2010 Aug 3.
6
Regulation and localization of cellular retinol-binding protein, retinol-binding protein, cellular retinoic acid-binding protein (CRABP), and CRABP II in the uterus of the pseudopregnant rat.假孕大鼠子宫中细胞视黄醇结合蛋白、视黄醇结合蛋白、细胞视黄酸结合蛋白(CRABP)和CRABP II的调节与定位
Endocrinology. 1996 Jul;137(7):3111-22. doi: 10.1210/endo.137.7.8770937.
7
4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors.4-羟基苯基视黄酸酰胺是一种视黄酸受体的高选择性激活剂。
J Biol Chem. 1996 Sep 13;271(37):22441-6. doi: 10.1074/jbc.271.37.22441.
8
Retinoid status and responsiveness to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking retinoid binding protein or retinoid receptor forms.缺乏类视黄醇结合蛋白或类视黄醇受体形式的小鼠的类视黄醇状态及对2,3,7,8-四氯二苯并对二恶英(TCDD)的反应性
Chem Biol Interact. 2005 Sep 10;156(1):25-39. doi: 10.1016/j.cbi.2005.06.006.
9
Molecular and metabolic retinoid pathways in the human ocular surface.人类眼表的分子和代谢类视黄醇途径。
Mol Vis. 2007 Sep 11;13:1641-50.
10
All-trans retinoic acid- and N-(4-hydroxyphenil)-retinamide-induced growth arrest and apoptosis in orbital fibroblasts in Graves' disease.全反式维甲酸和N-(4-羟基苯基)-视黄酰胺诱导Graves病眼眶成纤维细胞生长停滞和凋亡。
Metabolism. 2003 Nov;52(11):1387-92. doi: 10.1016/s0026-0495(03)00316-0.

引用本文的文献

1
Attempts to Improve Lipophilic Drugs' Solubility and Bioavailability: A Focus on Fenretinide.提高亲脂性药物溶解度和生物利用度的尝试:以芬维A胺为重点。
Pharmaceutics. 2024 Apr 24;16(5):579. doi: 10.3390/pharmaceutics16050579.
2
Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule.芬维 A 酯在癌症和神经退行性疾病中的作用:两面神分子。
Int J Mol Sci. 2022 Jul 4;23(13):7426. doi: 10.3390/ijms23137426.
3
Analysis of fenretinide and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics.
液相色谱-串联质谱法分析人血浆中的维甲酸及其代谢产物及其在临床药代动力学中的应用。
J Pharm Biomed Anal. 2017 Jan 5;132:117-124. doi: 10.1016/j.jpba.2016.09.046. Epub 2016 Sep 29.
4
Phase I trial of fenretinide lym-x-sorb oral powder in adults with solid tumors and lymphomas.口服芬维 A 酯乳胶剂在固体肿瘤和淋巴瘤成人患者中的 I 期临床试验。
Anticancer Res. 2011 Mar;31(3):961-6.
5
Cancer treatment strategies targeting sphingolipid metabolism.靶向鞘脂代谢的癌症治疗策略。
Adv Exp Med Biol. 2010;688:185-205. doi: 10.1007/978-1-4419-6741-1_13.
6
The Retinoic Acid Receptor-alpha mediates human T-cell activation and Th2 cytokine and chemokine production.维甲酸受体-α介导人类T细胞活化以及Th2细胞因子和趋化因子的产生。
BMC Immunol. 2008 Apr 16;9:16. doi: 10.1186/1471-2172-9-16.
7
Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells.维甲酸通过磷酸化 CREB 诱导胱天蛋白酶-8 转录,并增强神经母细胞瘤细胞对死亡刺激的凋亡反应。
Biochim Biophys Acta. 2008 Jun;1783(6):1055-67. doi: 10.1016/j.bbamcr.2008.02.007. Epub 2008 Mar 10.
8
Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs.N-(4-羟基苯基)视黄酰胺(4-HPR)类似物的小型文库的固相辅助合成与筛选。
Bioorg Med Chem Lett. 2007 Feb 1;17(3):836-40. doi: 10.1016/j.bmcl.2006.10.050. Epub 2006 Oct 25.
9
Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.小儿恶性肿瘤中的分化剂:神经母细胞瘤中的维甲酸
Curr Oncol Rep. 2000 Nov;2(6):511-8. doi: 10.1007/s11912-000-0104-y.